Other
Clinical Testing of Beverly Hills
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Early Phase 1
3(60.0%)
Phase 1
2(40.0%)
5Total
Early Phase 1(3)
Phase 1(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT06429033Phase 1Completed
Purified Exosome Product (PEP) Injected Into the Hypodermis
Role: lead
NCT05129319Early Phase 1Completed
Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD
Role: lead
NCT04886167Phase 1Unknown
Dysport Dose-Ranging Treatment of Platysmal Bands
Role: lead
NCT05305768Early Phase 1Unknown
Xeomin Treatment of Glabellar Lines Using OLD Versus COLD
Role: lead
NCT05083286Early Phase 1Unknown
Duration of Botox Using OLD Versus COLD for Treatment of Glabellar Lines
Role: lead
All 5 trials loaded